CS
ELAN icon

Credit Suisse’s Elanco Animal Health ELAN Stock Holding History

Credit Suisse’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$9.18M Sell
563,945
-15,630
-3% -$244K 0.01% 952
2023
Q4 		$8.64M Buy
579,575
+864
+0.1% +$9.79K 0.01% 1008
2023
Q3 		$6.5M Sell
578,711
-25,197
-4% -$293K 0.01% 1117
2023
Q2 		$6.08M Sell
603,908
-582,631
-49% -$5.41M 0.01% 1212
2023
Q1 		$11.2M Sell
1,186,539
-525,885
-31% -$6.2M 0.01% 882
2022
Q4 		$20.9M Sell
1,712,424
-16,460
-1% -$205K 0.02% 655
2022
Q3 		$21.5M Buy
1,728,884
+70,169
+4% +$1.23M 0.02% 639
2022
Q2 		$32.6M Buy
1,658,715
+12,550
+0.8% +$297K 0.03% 530
2022
Q1 		$42.9M Buy
1,646,165
+20,956
+1% +$558K 0.04% 502
2021
Q4 		$46.1M Buy
1,625,209
+148,212
+10% +$4.61M 0.02% 685
2021
Q3 		$47.1M Buy
1,476,997
+209,179
+16% +$7.02M 0.03% 667
2021
Q2 		$44.8M Sell
1,267,818
-142,824
-10% -$4.71M 0.02% 752
2021
Q1 		$41.5M Buy
1,410,642
+422,166
+43% +$13M 0.02% 786
2020
Q4 		$30.3M Sell
988,476
-268,168
-21% -$8.18M 0.01% 951
2020
Q3 		$35.1M Buy
1,256,644
+565,677
+82% +$14.3M 0.02% 762
2020
Q2 		$14.8M Buy
690,967
+239,327
+53% +$5.29M 0.01% 1098
2020
Q1 		$10.1M Sell
451,640
-586,445
-56% -$16.1M 0.01% 1178
2019
Q4 		$30.6M Buy
1,038,085
+47,449
+5% +$1.29M 0.02% 795
2019
Q3 		$26.3M Buy
990,636
+128,742
+15% +$3.86M 0.02% 759
2019
Q2 		$29.1M Sell
861,894
-182,481
-17% -$5.92M 0.03% 711
2019
Q1 		$33.5M Buy
+1,044,375
New +$32.1M 0.03% 594

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Credit Suisse's ELAN Position: Q1 2024 in Review

Credit Suisse reduced its Elanco Animal Health (ELAN) stake by 2.7% in Q1 2024, selling an estimated $244K and leaving 563,945 shares worth $9.18M. The position accounts for 0.01% of the portfolio, ranked #952.

Credit Suisse first reported a position in ELAN in Q1 2019 and has held it in 21 quarters since. The position peaked at $47.1M in Q3 2021. 376 funds tracked by Wall St. Rank hold ELAN as of Q1 2024.

  • Credit Suisse held 563,945 shares of Elanco Animal Health worth $9.18M as of Q1 2024.
  • Credit Suisse sold 15,630 Elanco Animal Health shares in Q1 2024, an estimated $244K.
  • Elanco Animal Health made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #952 holding.
  • Credit Suisse first reported a position in Elanco Animal Health in Q1 2019 and has held it in 21 quarters since.
  • Credit Suisse's Elanco Animal Health position peaked at $47.1M in Q3 2021.
  • 376 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.